Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO TrialJin Li, Shukui Qin, Haijun Zhong et al.|Advances in Therapy|2020Cited by 28
Subgroup Analysis by Prior Anti-VEGF or Anti-EGFR Target Therapy in FRESCO, a Randomized, Double-Blind, Phase III trialRui‐Hua Xu, Jin Li, Shukui Qin et al.|Future Oncology|2020Cited by 8
Abstract CT164: A phase 1 study of abemaciclib in Chinese patients with advanced and/or metastatic cancersXichun Hu, Sonya C. Chapman, Nong Yang et al.|Cancer Research|2020Cited by 0